{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T11:16:19Z","timestamp":1789384579096,"version":"build-2803163510"},"reference-count":30,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T00:00:00Z","timestamp":1569888000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100003107","name":"German Federal Ministry of Health","doi-asserted-by":"publisher","award":["ZMVI1-2516DSM216"],"award-info":[{"award-number":["ZMVI1-2516DSM216"]}],"id":[{"id":"10.13039\/501100003107","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Psychiatry Research"],"published-print":{"date-parts":[[2019,10]]},"DOI":"10.1016\/j.psychres.2019.112505","type":"journal-article","created":{"date-parts":[[2019,8,1]],"date-time":"2019-08-01T02:04:13Z","timestamp":1564625053000},"page":"112505","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":24,"special_numbering":"C","title":["Associations between methamphetamine use, psychiatric comorbidities and treatment outcome in two inpatient rehabilitation centers"],"prefix":"10.1016","volume":"280","author":[{"given":"Proebstl","family":"Lisa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kamp","family":"Felicia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hager","family":"Laura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Krause","family":"Daniela","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Riebschl\u00e4ger","family":"Marlies","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neumann","family":"Stefanie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Schacht Jablonowsky","family":"Maik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Schreiber","family":"Anne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Straif","family":"Maximilian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manz","family":"Kirsi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soyka","family":"Michael","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koller","family":"Gabi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.psychres.2019.112505_bib0001","unstructured":"Bose, J., Hedden, S.L., Lipari, R., Park-Lee, E., 2016. Key substance use and mental health indicators in the United States: rResults from the 2015 national survey on drug use and health. http:\/\/www.samhsa.gov\/data\/."},{"issue":"8","key":"10.1016\/j.psychres.2019.112505_bib0002","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1017\/S0033291703008353","article-title":"Pre-morbid characteristics and co-morbidity of methamphetamine users with and without psychosis","volume":"33","author":"Chen","year":"2003","journal-title":"Psychol. Med."},{"issue":"3","key":"10.1016\/j.psychres.2019.112505_bib0003","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1111\/jcpp.12036","article-title":"Practitioner review: current best practice in the management of adverse events during treatment with ADHD medications in children and adolescents","volume":"54","author":"Cortese","year":"2013","journal-title":"J. Child Psychol. Psychiatry Allied Discip."},{"issue":"3","key":"10.1016\/j.psychres.2019.112505_bib0004","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1080\/09595230801923702","article-title":"Major physical and psychological harms of methamphetamine use","volume":"27","author":"Darke","year":"2008","journal-title":"Drug Alcohol Rev."},{"key":"10.1016\/j.psychres.2019.112505_bib0005","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1055\/s-2002-23523","article-title":"R\u00fcckfallquote methamphetamin abh\u00e4ngiger Patientinnen nach niedrigschwelligen Drogenentzug - Ergebnisse einer mittelfristigen Katamnese","volume":"3","author":"Datzer","year":"2002","journal-title":"Suchttherapie"},{"issue":"Suppl 1","key":"10.1016\/j.psychres.2019.112505_bib0006","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1300\/J069v26S01_03","article-title":"Comorbidity and \"self-medication\"","volume":"26","author":"DuPont","year":"2007","journal-title":"J. Addict. Dis."},{"key":"10.1016\/j.psychres.2019.112505_bib0007","series-title":"The State of the Drugs Problem in Europe","year":"2010"},{"key":"10.1016\/j.psychres.2019.112505_bib0008","series-title":"The State of the Drugs Problem in Europe","year":"2017"},{"issue":"6","key":"10.1016\/j.psychres.2019.112505_bib0009","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1080\/1606635021000041807","article-title":"Cannabis effects and dependency concerns in long-term frequent users: a missing piece of the public health puzzle","volume":"11","author":"Hathaway","year":"2003","journal-title":"Addict. Res. Theory"},{"key":"10.1016\/j.psychres.2019.112505_bib0010","series-title":"BDI-II. Beck-Depressions-Inventar. Revision","author":"Hautzinger","year":"2009"},{"issue":"5","key":"10.1016\/j.psychres.2019.112505_bib0011","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1016\/S0306-4603(98)00078-1","article-title":"Relationship between substance abuse and panic attacks","volume":"24","author":"Katerndahl","year":"1999","journal-title":"Addict. Behav."},{"issue":"5","key":"10.1016\/j.psychres.2019.112505_bib0012","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1080\/16066350701284552","article-title":"Functional methamphetamine use: the insider's perspective","volume":"15","author":"Lende","year":"2007","journal-title":"Addict. Res. Theory"},{"key":"10.1016\/j.psychres.2019.112505_bib0013","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.maturitas.2018.12.003","article-title":"Methamphetamine and its immune-modulating effects","volume":"121","author":"Papageorgiou","year":"2019","journal-title":"Maturitas"},{"key":"10.1016\/j.psychres.2019.112505_bib0014","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1024\/0939-5911.a000277","article-title":"Komorbide substanzst\u00f6rungen in der allgemeinbev\u00f6lkerung","volume":"59","author":"Pinotek","year":"2013","journal-title":"SUCHT"},{"key":"10.1016\/j.psychres.2019.112505_bib0015","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.phrs.2017.03.009","article-title":"Methamphetamine: effects on the brain, gut and immune system","volume":"120","author":"Prakash","year":"2017","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.psychres.2019.112505_bib0016","unstructured":"Presser L. (Ed.), 2015. Gendered narratives of self, addiction and recovery among women methampetamine users."},{"key":"10.1016\/j.psychres.2019.112505_bib0017","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.eurpsy.2019.03.003","article-title":"Effects of stimulant drug use on the dopaminergic system: a systematic review and meta-analysis of in vivo neuroimaging studies","volume":"59","author":"Proebstl","year":"2019","journal-title":"Eur. Psychiatry"},{"issue":"2","key":"10.1016\/j.psychres.2019.112505_bib0019","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1001\/archpsyc.1993.01820140007001","article-title":"The de facto US mental and addictive disorders service system","volume":"50","author":"Regier","year":"1993","journal-title":"Arch. Gen. Psychiatry"},{"issue":"9","key":"10.1016\/j.psychres.2019.112505_bib0020","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1007\/s00115-001-1215-x","article-title":"Wender utah rating scale (WURS-k) die deutsche kurzform zur retrospektiven erfassung des hyperkinetischen syndroms bei erwachsenen","volume":"73","author":"Retz-Junginger","year":"2002","journal-title":"Der Nervenarzt"},{"issue":"2\u20133","key":"10.1016\/j.psychres.2019.112505_bib0021","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1016\/j.psychres.2010.09.014","article-title":"Psychiatric comorbidity in methamphetamine dependence","volume":"186","author":"Salo","year":"2011","journal-title":"Psychiatry Res."},{"issue":"3","key":"10.1016\/j.psychres.2019.112505_bib0022","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1124\/jpet.102.045005","article-title":"Methylphenidate alters vesicular monoamine transport and prevents methamphetamine-induced dopaminergic deficits","volume":"304","author":"Sandoval","year":"2003","journal-title":"J. Pharmacol. Exp. Ther."},{"issue":"2","key":"10.1016\/j.psychres.2019.112505_bib0023","first-page":"155","article-title":"Testbesprechung. Zeitschrift f\u00fcr psychiatrie","volume":"56","author":"Schmidt","year":"2008","journal-title":"Psychologie und Psychotherapie"},{"issue":"4","key":"10.1016\/j.psychres.2019.112505_bib0024","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1007\/s002130100917","article-title":"How does stress increase risk of drug abuse and relapse?","volume":"158","author":"Sinha","year":"2001","journal-title":"Psychopharmacology"},{"issue":"2","key":"10.1016\/j.psychres.2019.112505_bib0025","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1055\/s-0042-119862","article-title":"Pr\u00e4valenz und therapie bei abh\u00e4ngigkeit von methamphetamin (\u201eCrystal\u201c)","volume":"85","author":"Soyka","year":"2017","journal-title":"Fortschritte der Neurologie-Psychiatrie"},{"issue":"1","key":"10.1016\/j.psychres.2019.112505_bib0026","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1007\/s002780050007","article-title":"Pr\u00e4valenz traumatischer erfahrungen und posttraumatischer belastungsst\u00f6rung bei substanzabh\u00e4ngigen personen","volume":"45","author":"Teegen","year":"2000","journal-title":"Psychotherapeut"},{"key":"10.1016\/j.psychres.2019.112505_bib0027","doi-asserted-by":"crossref","first-page":"183","DOI":"10.3389\/fpsyt.2017.00183","article-title":"Development and validation of the amphetamine-type stimulants motive questionnaire in a clinical population","volume":"8","author":"Thurn","year":"2017","journal-title":"Front. Psychiatry"},{"key":"10.1016\/j.psychres.2019.112505_bib0028","unstructured":"United Nations Office on Drugs and Crime, 2018. World Drug report 2018."},{"issue":"3","key":"10.1016\/j.psychres.2019.112505_bib0029","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1176\/appi.ajp.158.3.377","article-title":"Association of dopamine transporter reduction with psychomotor impairment in methamphetamine abusers","volume":"158","author":"Volkow","year":"2001","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.psychres.2019.112505_bib0030","series-title":"Interviewheft Und Beurteilungsheft. Eine deutschsprachige, Erweiterte Bearbeitung Der Amerikanischen Originalversion Des SKID I","article-title":"SKID I. Strukturiertes klinisches interview f\u00fcr DSM-IV. Achse I: psychische st\u00f6rungen","author":"Wittchen","year":"1997"},{"issue":"2","key":"10.1016\/j.psychres.2019.112505_bib0031","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1080\/10550490490436055","article-title":"Psychiatric symptoms in methamphetamine users","volume":"13","author":"Zweben","year":"2004","journal-title":"Am. J. Addict."}],"container-title":["Psychiatry Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165178119310406?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165178119310406?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,9,21]],"date-time":"2019-09-21T19:38:13Z","timestamp":1569094693000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165178119310406"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,10]]},"references-count":30,"alternative-id":["S0165178119310406"],"URL":"https:\/\/doi.org\/10.1016\/j.psychres.2019.112505","relation":{},"ISSN":["0165-1781"],"issn-type":[{"value":"0165-1781","type":"print"}],"subject":[],"published":{"date-parts":[[2019,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Associations between methamphetamine use, psychiatric comorbidities and treatment outcome in two inpatient rehabilitation centers","name":"articletitle","label":"Article Title"},{"value":"Psychiatry Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.psychres.2019.112505","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"112505"}}